US-guided Hydro Dissection vs Fluoroscopy-guided Hydro Dissection for Adhesive Capsulitis

Launched by DISKAPI TEACHING AND RESEARCH HOSPITAL · Mar 17, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring the best way to treat shoulder pain caused by a condition known as adhesive capsulitis, commonly referred to as frozen shoulder. The study compares two methods of guiding a treatment called hydrodilatation therapy—one using ultrasound (a type of imaging that uses sound waves) and the other using fluoroscopy (a type of X-ray). The goal is to find out which method helps improve shoulder movement, reduces pain, and enhances overall shoulder function better.

To participate in this trial, individuals must be between the ages of 65 and 74 and have been diagnosed with frozen shoulder, experiencing significant pain (rated above 5 on a scale from 1 to 10). However, people with other shoulder problems, allergies to local anesthetics, or certain medical conditions that could affect their treatment are not eligible. Participants can expect to receive the hydrodilatation therapy with either ultrasound or fluoroscopy guidance, along with a nerve block to help manage pain. This study is currently recruiting, and your involvement could help improve treatment options for frozen shoulder in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of frozen shoulder disease
• • VAS\>5
• Exclusion Criteria:
• • Other shoulder diseases that may cause shoulder pain (Rotator cuff tear, clavicle fracture, etc.)
• • Allergy to local anesthetics
• • History of shoulder surgery in the last 12 months
• • Pregnancy
• • Coagulopathy or antiplatelet use
• • The patient has a mental illness that prevents decision-making